DK174094B1 - Polypeptider og polypeptidsammensætninger samt antistoffer herimod, DNA-sekvenser kodende herfor; diagnostiske sæt omfattende antistoffer og polypeptider; anvendelse af polypeptider til diagnostiske formål, til fremstilling af lægemidler...... - Google Patents

Polypeptider og polypeptidsammensætninger samt antistoffer herimod, DNA-sekvenser kodende herfor; diagnostiske sæt omfattende antistoffer og polypeptider; anvendelse af polypeptider til diagnostiske formål, til fremstilling af lægemidler...... Download PDF

Info

Publication number
DK174094B1
DK174094B1 DK198606153A DK615386A DK174094B1 DK 174094 B1 DK174094 B1 DK 174094B1 DK 198606153 A DK198606153 A DK 198606153A DK 615386 A DK615386 A DK 615386A DK 174094 B1 DK174094 B1 DK 174094B1
Authority
DK
Denmark
Prior art keywords
polypeptide
cells
composition
manufacture
polypeptide composition
Prior art date
Application number
DK198606153A
Other languages
Danish (da)
English (en)
Other versions
DK615386D0 (da
DK615386A (da
Inventor
Mohammed Shoyab
Joyce M Zarling
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Brown
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of DK615386D0 publication Critical patent/DK615386D0/da
Publication of DK615386A publication Critical patent/DK615386A/da
Application granted granted Critical
Publication of DK174094B1 publication Critical patent/DK174094B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198606153A 1985-12-20 1986-12-18 Polypeptider og polypeptidsammensætninger samt antistoffer herimod, DNA-sekvenser kodende herfor; diagnostiske sæt omfattende antistoffer og polypeptider; anvendelse af polypeptider til diagnostiske formål, til fremstilling af lægemidler...... DK174094B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US81123585 1985-12-20
US93528386A 1986-11-26 1986-11-26
US93528386 1986-11-26

Publications (3)

Publication Number Publication Date
DK615386D0 DK615386D0 (da) 1986-12-18
DK615386A DK615386A (da) 1987-06-21
DK174094B1 true DK174094B1 (da) 2002-06-10

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198606153A DK174094B1 (da) 1985-12-20 1986-12-18 Polypeptider og polypeptidsammensætninger samt antistoffer herimod, DNA-sekvenser kodende herfor; diagnostiske sæt omfattende antistoffer og polypeptider; anvendelse af polypeptider til diagnostiske formål, til fremstilling af lægemidler......

Country Status (29)

Country Link
JP (1) JP2559035B2 (fi)
KR (1) KR920005920B1 (fi)
CN (1) CN1017626B (fi)
AT (1) AT400444B (fi)
AU (2) AU601168B2 (fi)
BE (1) BE905957A (fi)
CA (1) CA1340296C (fi)
CH (1) CH675727A5 (fi)
CY (1) CY1608A (fi)
DE (2) DE3643428A1 (fi)
DK (1) DK174094B1 (fi)
ES (1) ES2003180A6 (fi)
FI (1) FI91484C (fi)
FR (1) FR2597108B1 (fi)
GB (1) GB2185485B (fi)
GR (1) GR862936B (fi)
HK (1) HK65691A (fi)
HU (1) HU210694B (fi)
IE (1) IE59415B1 (fi)
IL (1) IL81017A (fi)
IT (1) IT1213428B (fi)
LU (1) LU86718A1 (fi)
NL (1) NL8603209A (fi)
NO (1) NO174556C (fi)
NZ (1) NZ218634A (fi)
OA (1) OA08494A (fi)
PT (1) PT83986B (fi)
SE (1) SE505059C2 (fi)
SG (1) SG60891G (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
NZ237533A (en) * 1990-03-29 1992-12-23 Bristol Myers Squibb Co Monoclonal antibodies which bind to oncostatin m, cell lines producing them
ZA912137B (en) * 1990-03-29 1992-11-25 Oncogen Monocional antibodies that inhibit growth of kaposi's sarcoma
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
ZA936925B (en) * 1992-09-25 1995-03-20 Lilly Co Eli Modified platelet factor-4.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
GB2185485A (en) 1987-07-22
NL8603209A (nl) 1987-07-16
NO865178L (no) 1987-06-22
GB8629997D0 (en) 1987-01-28
FR2597108B1 (fr) 1991-02-15
IL81017A0 (en) 1987-03-31
FI91484C (fi) 1994-07-11
OA08494A (fr) 1988-07-29
AU639048B2 (en) 1993-07-15
AU601168B2 (en) 1990-09-06
AU6660886A (en) 1987-06-25
DK615386D0 (da) 1986-12-18
HUT43103A (en) 1987-09-28
SE8605459D0 (sv) 1986-12-18
KR870005645A (ko) 1987-07-06
LU86718A1 (fr) 1988-07-14
SE505059C2 (sv) 1997-06-16
CA1340296C (en) 1998-12-29
HU210694B (en) 1995-06-28
PT83986A (en) 1987-01-01
NO174556B (no) 1994-02-14
JPS62236498A (ja) 1987-10-16
DE3645095C2 (de) 1993-11-18
ATA340686A (de) 1995-05-15
IT1213428B (it) 1989-12-20
DE3643428C2 (fi) 1990-08-23
KR920005920B1 (ko) 1992-07-24
DK615386A (da) 1987-06-21
GB2185485B (en) 1990-07-04
DE3643428A1 (de) 1987-09-24
FR2597108A1 (fr) 1987-10-16
IL81017A (en) 1993-01-14
CN1017626B (zh) 1992-07-29
AT400444B (de) 1995-12-27
IE863345L (en) 1987-06-20
AU6776590A (en) 1991-03-14
FI91484B (fi) 1994-03-31
HK65691A (en) 1991-08-23
IE59415B1 (en) 1994-02-23
NZ218634A (en) 1991-06-25
CH675727A5 (fi) 1990-10-31
CY1608A (en) 1992-04-03
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
JP2559035B2 (ja) 1996-11-27
BE905957A (fr) 1987-06-17
SE8605459L (sv) 1987-06-21
IT8622787A0 (it) 1986-12-19
CN86108955A (zh) 1987-12-02
NO865178D0 (no) 1986-12-19
NO174556C (no) 1994-05-25
ES2003180A6 (es) 1988-10-16
SG60891G (en) 1991-08-23
PT83986B (pt) 1989-07-31
GR862936B (en) 1987-10-28

Similar Documents

Publication Publication Date Title
DK171600B1 (da) Immunosuppressiv faktor og fremgangsmåde til fremstilling af denne faktor
DK174094B1 (da) Polypeptider og polypeptidsammensætninger samt antistoffer herimod, DNA-sekvenser kodende herfor; diagnostiske sæt omfattende antistoffer og polypeptider; anvendelse af polypeptider til diagnostiske formål, til fremstilling af lægemidler......
EP0290948A2 (en) Oncostatin M and novel compositions having anti-neoplastic activity
US5874536A (en) Proteins with Oncostatin M activity and process for their preparation
US7550438B2 (en) Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
IE840999L (en) Polypeptides
US5262298A (en) Method to assess the ability of a substance to inhibit or stimulate keratinocyte autocrine factor production
US6096706A (en) Growth-promoting proteins and peptides for kidney epithelial cells
AU651330B2 (en) Novel proteins with oncostatin M activity and process for their preparation
FI98373B (fi) Uusi diagnostisesti käyttökelpoinen polypeptidi, onkostatiini M
EP0234545A2 (en) Purified human angiogenic factor, method for its preparation and pharmaceutical preparations
US5147798A (en) Monophenotypic xenograft of megakaryocytic lineage and origin
WO1990014069A2 (en) Keratinocyte autocrine factor
IE904732A1 (en) Novel proteins with oncostatin m activity and process for¹their preparation
NZ231140A (en) Transforming growth factor (tgf) and its isolation

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired